Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Krsnaa Diagnostics Limited Capital/Financing Update 2021

Nov 12, 2021

59415_rns_2021-11-12_3182ef8c-1824-4ce7-9b38-c80192686d3d.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

0 Krs d DI AGNOSTICS' LET'S DO GOOD ... ®

Date: 12[th ] November, 2021

BSE Ltd.

Corporate Service Department, p[t ] Floor, P. J. Towers, Dalal Street, Mumbai 400 001

The National Stock Exchange of India Ltd. Exchange Plaza, 3[rd ] Floor, Plot No. C/1, 'G' Block, Bandra Kurla Complex, Bandra (E}, Mumbai 400 051

Scrip ID: KRSNAA Scrip Code: 543328

Symbol: KRSNAA Series: EQ

Dear Sir / Madam,

Subject: Report of Monitoring Agency for the Initial Public Offer

Pursuant to Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we have attached herewith, a Report of Monitoring Agency i.e. ICICI Bank Limited for the quarter ended 30[th ] September, 2021.

You are requested to take the same on your record.

Thanking you, Yours sincerely,

For Krsnaa Diagnostics Limited

==> picture [186 x 96] intentionally omitted <==

----- Start of picture text -----

��
-
Nikhil Deshpande
Company Secretary �
Encl: A/a
----- End of picture text -----

Krsnaa Diagnostics Ltd. (Formerly known as Krsnaa Diagnostics Pvt. Ltd.) S.No. 243/A, Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station, - - Chinchwad, Taluka Haveli, Pune, MH 411019 (India) 020 29780210 / 11 / 12 I [email protected] CIN : L74900PN2010PLC138068

www.krsnaadiagnost1cs.com j 11 I l� I Ni I 111'1 j ITT

IC/Cl Bank (I

Report of the Monitoring Agency

Name of the Issuer: Krsnaa Diagnosticslimtted For quarter ended: Sept 30, 2021 Name of the Monitoring Agency: ICICI Bank Limited

(a) Deviation from the objects: No deviation from the object

(bl Range of Deviation: Not applicable

Declaration:

We declare that this report is based on the format prescnbed by the SEBI (ICDR) Regulations, 2018, We further declare that this report provides a true and fair view of the utilization of the issue proceeds.

We declare that we do not have any direct/indirect interest in or relationship with the issuer/promoters/ directors/management and also confirm that we do not perceive any conflict of interest in such relationship/interest whtle m<?nitoring and reporting the ut!lization of the i ue proceeds by the issuer.

Signature:

==> picture [96 x 30] intentionally omitted <==

==> picture [74 x 70] intentionally omitted <==

Name of the Authorized Person/Signing Authority: Sagar Welekar Designation of Authorized person/Signing Authority: Manager Seal of the Monitoring Agency: Date: Nov 10, 2021

Regd. Office : ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara 390 007, India,

ICICI Bank Limited 122, 1st Floor, Capital Market Division, Mumbai - 400 020, Maharashtra, India.

Tel. : 022-66818817 / 66818900 Website www.icicibank.com CIN :L65190GJ1994PLC027012

Corp, Office : ICICI Bank Towers, Bandra-Kurla Complex, Mumbai 400051, India.

fl IC/Cl Bank

==> picture [53 x 27] intentionally omitted <==

1) Issuer Details:

Name of the issuer: Krsnaa Diagnosticslimited Names of the promoter: Rajendra Mutha Industry/sector to which it belongs: Diagnostic services provider

2) Issue Details:

Issue Period: Aug 4, 2021 to Aug 6, 2021 Type of issue (public/rights): Initial Public Offer Type of specified securities: Equity Shares Public Issue Grading, if any: NA Issue size(' in million): 12133.3

3) Details of the arrangement made to ensure the monitoring of issue proceeds:

3) Details of the arrangement made to ensure the monitoring of issue proceeds: 3) Details of the arrangement made to ensure the monitoring of issue proceeds: 3) Details of the arrangement made to ensure the monitoring of issue proceeds: 3) Details of the arrangement made to ensure the monitoring of issue proceeds: 3) Details of the arrangement made to ensure the monitoring of issue proceeds:
(Give item by item description for all the objects stated in offer document separately in following format)
Particulars
Reply
Commentsofthe
Comments of the
Monitorina Aaency
Board of Directors
Whether allutilization is as per the disclosures in the Offer
Document?
Yes/No
Yes
Yes
Whether shareholder approval has been obtained in case of
Yes/No
material deviations# from expenditures disclosed in the Offer
NA
NA
Document?
Whether the means of finance for the disclosed objects of the
Yes/No
No
No
issue has changed?
ls there any major deviation observed over the earlier monitoring
Yes/No
agency repors?
NA
NA
WhetherallGovernmentstatutory approvalsrelated
obiect(s) have been obtained?
tothe
Yes/No
NA
Yes
Whether
all
arrangements
pertaining
assistance/collaboration are in operation?
to
technical
Yes/No
NA
Yes
Are there any favorable events improving the viability of these
Yes/No
NA
No
object(s)>
Are there. any unfavorable events affecting the viability of the
Yes/No
No
No
obiect(s)?
Is there any other relevant information that may materially affect
Yes/No
NA
No
the decision makina of the investors?

Commentsofthe
Monitorina Aaency		 Comments of the
Board of Directors
Yes
Whether allutilization is as per the disclosures in the Offer
Document?
Yes/No
Whether shareholder approval has been obtained in case of
Yes/No
material deviations# from expenditures disclosed in the Offer
Document?
Whether the means of finance for the disclosed objects of the
Yes/No
issue has changed?
ls there any major deviation observed over the earlier monitoring
Yes/No
agency repors?
WhetherallGovernmentstatutory approvalsrelated
obiect(s) have been obtained?
tothe
Yes/No
Whether
all
arrangements
pertaining
assistance/collaboration are in operation?
to
technical
Yes/No
Are there any favorable events improving the viability of these
Yes/No
object(s)>
Are there. any unfavorable events affecting the viability of the
Yes/No
obiect(s)?
Is there any other relevant information that may materially affect
Yes/No
the decision makina of the investors?		 Yes
NA
No
NA
NA
NA
No
NA
Yes
Yes
No
No
No
NA
NA
No
NA

*Where material deviation may be defined to mean:

a) Deviation in the objects or purposes for which the funds have been raised

b) Deviation in the amount of fund actually utilized by more than 10% of the amount projected in the offer documents.

ICICI Bank Limited

122, 1st Floor, Capital Market Division, Mumbai - 4 020, Maharashtra, India.

Tel.: 022-66818817 / 66818900 Website www.icicibank.com CIN :L65190GJ1994PLC021012

Regd, Office : ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara 390 007, India,

Corp. Office : ICICI Bank Towers, Bandra-Kurla Complex, Mumbai 40 051, India.

/CIC/ Bank fl

41 Details of object(s)s to be monitored:

41 Details of object(s)s to be monitored: 41 Details of object(s)s to be monitored: 41 Details of object(s)s to be monitored:
Iii
Cost of obJect(s� INR in Million
Sr.
No
Item Head
Original
Cost
(as
per
Offer
Document)		 Revise
Cost		 Comments
of
Monitoring
Agency		 Comments of Board of Directors
Reason
of
cost
revision		 Proposed
financing
option		 Pariculars
of
firm
arrangements
made
1
Finance the cost of
establishing
d iag nasties
1,508.10
centres at Punjab,
Karnataka,
HimachalPradesh
and Maharashtra
 1,508.10 No
Comments		 No
Comments		 No
Comments		 No Comments
2
Repayment/pre
payment, in full or
part, of borrowings
frombanks and
1460.81
other
lenders
availed
by
our
Company		 1460.81 No
Comments		 No
Comments		 No
Comments		 No Comments
3
Generalcorporate
purposes*
817.41
 813.05 No
Comments		 No
Comments		 No
Comments		 No Comments
Totl
3,786.32		 3,781.96

(*)Amount proposed to be utilized for General Corporate Purposes is revised to INR 813.05 million as compared to original amount of INR. 817.41 million, on account of revision in estimation of IPO Expense.

(ii) Progress in the object(s� INR in Million

Sr.
No
Item Head		 Amount
as
proposed
in
Offer
Document		 Amount utilized Total
unutilized
Amount
Comments
Commentsof Board of
of
Directors
Monitoring
Aaency		 Total
unutilized
Amount
Comments
Commentsof Board of
of
Directors
Monitoring
Aaency
As at
Beginning
of the
quarter
During
At
the
the
end
of
quarter
the
quarer
Reasonof
Proposed
idle funds
Courseof
Action
1
Finance the cost
of
establishing
diagnostics
centres
at
Punjab,
Karnataka,
Himachal
Pradesh
and
Maharashtra		 1,508.10
99.90
99.90
1,408.20		 No
No
Comments
Comments
2
Repayment/pre-
payment, in full
or
par,
of
borrowings from
banks and other
lenders
availed
by
our
Company*		 1460.81

Regd, Office : ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara 390 007, India.

ICICI Bank Limited

122, 1st Floor, Capital Market Division, Mumbai - 400 020, Maharashtra, India,

Tei,: 022-66818817 / 66818900 Website w .icicibank.com CIN :L65190GJ1994PLC021012

Corp, Office : ICICI Bank Towers, Bandra-Kurla Complex, Mumbai 400051, India.

fl 1c1c1 Bank

3 General
corporate
purposes		 813.05 . . . 813.05 No
Comments		 No
Comments		 No
Comments
Totl 3,781.9 1,528.40 1,528.40 2,253.56

(*)Prepayment of Term Loan from lnduslnd bank Ltd, ICICI Bank Limited. lnduslnd Bank Limited, HDFC bank Ltd & NBFCs

(
SI
No
1
2
3
4
5
6		 iii)
Deployment of unutilized Public offer proceeds- INR In millions		 iii)
Deployment of unutilized Public offer proceeds- INR In millions		 iii)
Deployment of unutilized Public offer proceeds- INR In millions
Type of instrument and name of the
entity invested in
Fixed Deposit -lnduslnd bank Ltd -
300866867909		 Amount
Invested
300.00		 Maturity date
October 16, 2021		 Earnings**
0.41		 Market
Return on
Value as
Investment
at the end
(ROI%)
of
quarter*
3.10%
NA
Fixed Deposit -lnduslnd bank Ltd .
650.00
March 27, 2022
300870569776
Fixed Deposit -Yes Bank Ltd -
300.00
March 27. 2022
064840300009573
Fixed Deposit -Yes Bank Ltd -
350.00
October 31, 2021
064840300009626
Fixed Deposit -HDFC bank Ld -
600.00
April 01, 2022
50200014917705
Balance in Monitoring Account - ICICI
62.06
NA
Total
2262.06*		 0.28
0.16
0.03
0.06
NA
0.9		 4.00%
NA
4.85%
NA
3.40%
NA
3.50%
NA
NA
NA
.
  • Total amount invested is higher than the unutilized amount as it includes interest earned on fixed deposits & amount pending to be paid for IPO Expense.

Earnings represents the· amount of interest earned & accrued on the fixed deposits from the date of Investment to September** 30, 2021

==> picture [486 x 172] intentionally omitted <==

----- Start of picture text -----

(iv) Delay in implementation of the object(s)-
Object[s) Name Completion Date Delay (No. of Comments of Board of Directors
davs/ months)
As per Offer Actual Reason of delay Proposed Course of Action
Document
Signature: 4-2�
Name of the Authorized Person/Signing Authorit ar lekar
Designation of Authorized person/Signing Authority: Manager
Seal of the Monitoring Agency:
Date: Nov 10. 2021
----- End of picture text -----

Regd. Offce : ICICI Bank Tower, Near Chakli Circle, Old Padra Road, Vadodara 390 007, India,

ICICI Bank Limited

122, 1st Floor, Capital Market Division, Mumbai - 400 020, Maharashtra, India.

Tel.: 022-66818817 / 66818900 Website www.icicibank.com GIN :L65190GJ1994PLC021012

Corp. Offce : ICICI Bank Towers, Bandra-Kurla Complex, Mumbai 400051, India.

More from Krsnaa Diagnostics Limited

Earnings Release 2026
May 27
Earnings Release 2026
May 27
Regulatory Filings 2026
May 26
Regulatory Filings 2026
May 26
Investor Presentation 2026
May 25
Investor Presentation 2026
May 25
Earnings Release 2026
May 25
Earnings Release 2026
May 25
Audit Report / Information 2026
May 25
Audit Report / Information 2026
May 25
View all filings →